Persones / Equip Humà

F. Xavier Palomer Tarridas

Buscador de publicacions

Publicacions

  • Rostami A, Palomer FX, Pizarro J, Barroso E, Valenzuela-Alcaraz BI, Fàtima Crispi Brillas, Nistal JF, Hurlé MA, García R, Wahli W and Vazquez M.

    PPARß/d prevents inflammation and fibrosis during diabetic cardiomyopathy.

    PHARMACOLOGICAL RESEARCH . 210: 107515-107515.

    [doi:10.1016/j.phrs.2024.107515]

  • Barroso E, Jurado-Aguilar J, Wahli W, Palomer FX and Vazquez M.

    Increased hepatic gluconeogenesis and type 2 diabetes mellitus.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 35(12): 1062-1077.

    [doi:10.1016/j.tem.2024.05.006]

  • Zhang M, Barroso E, Peña L, Rada P, Valverde ÁM, Wahli W, Palomer FX and Vazquez M.

    PPARß/d attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells.

    BIOMEDICINE & PHARMACOTHERAPY . 179: 117303-117303. Nº de cites: 1

    [doi:10.1016/j.biopha.2024.117303]

  • Palomer FX, Salvador JM, Griñán-Ferré C, Barroso E, Pallàs M and Vazquez M.

    GADD45A: With or without you

    MEDICINAL RESEARCH REVIEWS . 44(4): 1375-1403. Nº de cites: 9

    [doi:10.1002/med.22015]

  • Peyman M, Babin-Ebell A, Rodríguez-Rodríguez R, Rigon M, Aguilar-Recarte D, Villarroya-Terrade J, Planavila A, Villarroya-Gombau F, Palomer FX, Barroso E and Vazquez M.

    SIRT1 regulates hepatic vldlr levels

    CELL COMMUNICATION AND SIGNALING . 22(1): 297-297. Nº de cites: 1

    [doi:10.1186/s12964-024-01666-y]

  • Griñán-Ferré C, Jarne-Ferrer J, Bellver-Sanchis A, Ribalta-Vilella M, Barroso E, Salvador JM, Jurado-Aguilar J, Palomer FX, Vazquez M and Pallàs M.

    Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer's Disease Hallmarks

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 25(5): . Nº de cites: 1

    [doi:10.3390/ijms25052595]

  • Jurado-Aguilar J, Barroso E, Bernard M, Zhang M, Peyman M, Rada P, Valverde ÁM, Wahli W, Palomer FX and Vazquez M.

    GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-ß1/SMAD3 pathway

    METABOLISM-CLINICAL AND EXPERIMENTAL . 152: 155772-155772. Nº de cites: 8

    [doi:10.1016/j.metabol.2023.155772]

  • Peyman M, Barroso E, Turcu AL, Estrany F Jr, Smith D, Jurado-Aguilar J, Rada P, Morisseau C, Hammock BD, Valverde ÁM, Palomer FX, Galdeano C, Vázquez S and Vazquez M.

    Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress

    BIOMEDICINE & PHARMACOTHERAPY . 168: 115667-115667. Nº de cites: 3

    [doi:10.1016/j.biopha.2023.115667]

  • Barroso E, Díaz M, Reguera AC, Peyman M, Balsinde J, Jurado-Aguilar J, Zhang M, Rostami A, Palomer FX, Ibañez-Toda L and Vazquez M.

    CHOP upregulation and dysregulation of the mature form of the SNAT2 amino acid transporter in the placentas from small for gestational age newborns

    CELL COMMUNICATION AND SIGNALING . 21(1): 326-326. Nº de cites: 1

    [doi:10.1186/s12964-023-01352-5]

  • Zhang M, Barroso E, Ruart M, Peña L, Peyman M, Aguilar-Recarte D, Montori M, Rada P, Cugat C, Montironi C, Zarei M, Jurado-Aguilar J, Camins A, Balsinde J, Valverde ÁM, Wahli W, Palomer FX and Vazquez M.

    Elafibranor upregulates the EMT-inducer S100A4 via PPARß/d

    BIOMEDICINE & PHARMACOTHERAPY . 167: 115623-115623. Nº de cites: 3

    [doi:10.1016/j.biopha.2023.115623]